Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (1443)	3/6/2000 3:57:00 PM
From: RIP	Read Replies (2) \| Respond to of 1476

Mike, I know it's been a long time since I posted...but still in ANTX...a little less than before (sold some on the way up). I still have a large position and so do friends, family and the little S%#T Gopher. We are planning on making the meeting this year. Terri said it would be second week of June (as always). Main reason I'm writing is that last night (Sunday) on the CBS Evening News they mentioned that CBS Health Watch this week would be about people getting "deadly sick" from hospital stays! Remember the 12 Jan news...and I quote: "The costs of antibiotic resistance continue to rise. Mortality and hospital length of stay are at least doubled for resistant strains of some pathogens. Hospital-acquired infections caused by drug-resistant bacteria and other pathogens cost an estimated $30 billion each year, according to a National Institutes of Health (NIH) report. Some bacteria causing various infectious diseases are resistant to multiple antibiotics and the number of bacteria is continuing to increase. Major resistant nosocomial pathogens include Staphylococcus aureus, Streptococcus, Enterococci, Pseudomonas, and Enterobacter including Escherichia coli and Klebsiella. From 1989 through 1993, the percentage of nosocomial enterococcal infections reported to the Centers for Disease Control and Prevention (CDC) National Nosocomial Infections Surveillance (NNIS) System that were caused by VRE increased from 0.3% to 7.9%. The increase was due mainly to the 34-fold rise of VRE infections in intensive-care unit (ICU) patients." Not sure if this will air all week on CBS, tonight only??? Did not catch the complete time. Looking forward to meeting, RIP